Bristol Myers Squibb (BMY) and Pfizer (PFE) Thursday announced a direct-to-patient option for purchasing their blood thinner medicine, Eliquis through the partnership's patient resource Eliquis 360 Support.
Beginning September 8, eligible U.S. patients with an Eliquis prescription can purchase the medicine directly at a discount of more than 40%.
"With more than 15 million Americans having been prescribed Eliquis since it was first launched, the medicine has resulted in an estimated $3 billion in total healthcare cost savings and avoidance, such as hospitalization and extended rehabilitation needs, for every 100,000 patients treated," BMY said in a statement.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.